These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15811643)

  • 1. Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF.
    Kim HD; Cao Y; Kong FK; Van Kampen KR; Lewis TL; Ma Z; Tang DC; Fukuchi K
    Vaccine; 2005 Apr; 23(23):2977-86. PubMed ID: 15811643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of Alzheimer model mice with adenovirus vectors encoding amyloid beta-protein and GM-CSF reduces amyloid load in the brain.
    Kim HD; Kong FK; Cao Y; Lewis TL; Kim H; Tang DC; Fukuchi K
    Neurosci Lett; 2004 Nov; 370(2-3):218-23. PubMed ID: 15488326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
    Kim HD; Maxwell JA; Kong FK; Tang DC; Fukuchi K
    Biochem Biophys Res Commun; 2005 Oct; 336(1):84-92. PubMed ID: 16126169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
    Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
    J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with amyloid-beta using GM-CSF and IL-4 reduces amyloid burden and alters plaque morphology.
    DaSilva K; Brown ME; Westaway D; McLaurin J
    Neurobiol Dis; 2006 Aug; 23(2):433-44. PubMed ID: 16766202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal inoculation of an adenovirus vector encoding 11 tandem repeats of Abeta1-6 upregulates IL-10 expression and reduces amyloid load in a Mo/Hu APPswe PS1dE9 mouse model of Alzheimer's disease.
    Kim HD; Tahara K; Maxwell JA; Lalonde R; Fukuiwa T; Fujihashi K; Van Kampen KR; Kong FK; Tang DC; Fukuchi K
    J Gene Med; 2007 Feb; 9(2):88-98. PubMed ID: 17219449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Th2 immunity after DNA prime-protein boost immunization with amyloid beta (1-42) plus CpG oligodeoxynucleotides in aged rats.
    Subramanian S; Divya Shree AN
    Neurosci Lett; 2008 May; 436(2):219-22. PubMed ID: 18394801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
    Seabrook TJ; Thomas K; Jiang L; Bloom J; Spooner E; Maier M; Bitan G; Lemere CA
    Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
    Bernt KM; Ni S; Tieu AT; Lieber A
    Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.
    Seabrook TJ; Iglesias M; Bloom JK; Spooner ET; Lemere CA
    Vaccine; 2004 Sep; 22(29-30):4075-83. PubMed ID: 15364459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
    DaSilva KA; Brown ME; McLaurin J
    Vaccine; 2009 Feb; 27(9):1365-76. PubMed ID: 19150380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The granulocyte macrophage colony stimulating factor (GM-CSF) regulates amyloid beta (Abeta) production.
    Volmar CH; Ait-Ghezala G; Frieling J; Paris D; Mullan MJ
    Cytokine; 2008 Jun; 42(3):336-44. PubMed ID: 18434187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
    Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
    Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B; Rangel M; Hunter Z; Peabody DS
    Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with Abeta-displaying virus-like particles reduces soluble and insoluble cerebral Abeta and lowers plaque burden in APP transgenic mice.
    Bach P; Tschäpe JA; Kopietz F; Braun G; Baade JK; Wiederhold KH; Staufenbiel M; Prinz M; Deller T; Kalinke U; Buchholz CJ; Müller UC
    J Immunol; 2009 Jun; 182(12):7613-24. PubMed ID: 19494285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular immunization with a plasmid DNA vaccine encoding prM-E protein from Japanese encephalitis virus: enhanced immunogenicity by co-administration of GM-CSF gene and genetic fusions of prM-E protein and GM-CSF.
    Zhai YZ; Li XM; Zhou Y; Ma L; Feng GH
    Intervirology; 2009; 52(3):152-63. PubMed ID: 19521104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 induces Th2 immune response against amyloid-β in wild-type mouse.
    Li Y; Ma Y; Zong LX; Xing XN; Sha S; Cao YP
    Neurosci Lett; 2011 Nov; 505(2):128-33. PubMed ID: 22005583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.